Biosensors International
20250 Acacia Street, #115
Newport Beach
California
92660
United States
Tel: 949-553-8300
Fax: 949-553-9129
Website: http://www.biosensors.com.sg/
Email: sales@biosensors-usa.com
63 articles about Biosensors International
-
BIOSENSORS ANNOUNCES PRIMARY ENDPOINT DATA RELEASE OF THE NEW US PIVOTAL BIOFREEDOM TRIAL – “LEADERS FREE II”
9/22/2018
Biosensors International Group, Ltd. and BlueSail Medical (Biosensors or the “Company”, stock exchange code 002382.SZ), a developer, manufacturer and marketer of innovative medical devices, announced today that primary endpoint results of the LEADERS FREE II trial were presented at the TCT 2018 conference in San Diego, CA, USA.
-
Biosensors International Announces Enrollment Of The First American Patient In The New US Pivotal Biofreedom Trial - "LEADERS FREE II"
3/22/2017
-
Biosensors International Announces Enrollment Of First Patient In New U.S. Pivotal BioFreedom Trial – "LEADERS FREE II"
2/15/2017
-
Biosensors International Announces Strategic Agreement With Cardinal Health
5/12/2016
-
CITIC In Talks To Acquire Singapore's Biosensors International
10/29/2015
-
Biosensors International Reports Financial Results For The First Quarter Of Fiscal Year 2016
8/3/2015
-
Biosensors International Reports Financial Results For Fiscal Year 2015
5/27/2015
-
Biosensors International Release: Large International Registry Confirms The Long-Term Safety And Efficacy Of The BioMatrix DES Family Observed In LEADERS
5/21/2015
-
Biosensors International Release: CREDIT II Stent Trial Completes Enrollment
3/11/2015
-
Biosensors International Reports Financial Results For The Third Quarter Of Fiscal Year 2015
2/12/2015
-
Biosensors International Release: LEADERS Free Japan Trial Completes Enrollment
2/9/2015
-
Biosensors International Release: Leaders Free Japan Trial Completes Enrollment
2/9/2015
-
Biosensors International Enters Into Distribution Agreement With Veryan Medical Limited For BioMimics 3D Stent
1/28/2015
-
Biosensors International Reports Financial Results For The Second Quarter And First Half Of Fiscal Year 2015
11/12/2014
-
Biosensors International Reports Financial Results For The First Quarter Of Fiscal Year 2015
8/6/2014
-
Biosensors International Release: LEADERS Free Japan Trial Enrolls First Patient
6/17/2014
-
Biosensors International Taps Ex-Abbott Vascular Exec For Top Post
5/29/2014
-
Biosensors International Reports Financial Results For Fiscal Year 2014
5/28/2014
-
Biosensors International Launches Next Generation Cobalt Chromium Bare-Metal Stent
5/19/2014
-
Biosensors International Announces IDE Approval For BioFreedom U.S. Trial
5/5/2014